Computational Modeling and Evaluation of Potential mRNA and Peptide-Based Vaccine against Marburg Virus (MARV) to Provide Immune Protection against Hemorrhagic Fever

Figure 10

In silico simulation triggered by mRNA vaccine. (a) Antigen count per ml for 3 doses. (b) Ab response to antigen injections.

(a)

(b)